Survival of pancreatic cancer cells lacking KRAS function
Pancreatic cancer cells may develop resistance to KRAS inhibitors due to activation of compensatory pathways. In this study, the authors demonstrate that KRAS is dispensable in a subset of pancreatic cancer and that PI3K signalling may have an important role in mediating tumor growth following KRAS...
Guardado en:
Autores principales: | Mandar Deepak Muzumdar, Pan-Yu Chen, Kimberly Judith Dorans, Katherine Minjee Chung, Arjun Bhutkar, Erin Hong, Elisa M. Noll, Martin R. Sprick, Andreas Trumpp, Tyler Jacks |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d398db26f7f440fbdb14fc260d45e14 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
por: Mandar Deepak Muzumdar, et al.
Publicado: (2016) -
KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
por: Shuang-Ni Yu, et al.
Publicado: (2016) -
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients
por: Madiha Naseem, et al.
Publicado: (2021) -
Publisher Correction: Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice
por: Marta Cáceres, et al.
Publicado: (2021) -
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
por: Naiara Santana-Codina, et al.
Publicado: (2018)